6Samia Mora, Nader Rifai, Julie E. Buring, ct al. Additive Value of Immunoassay - Measured Fibfinogen and High - Sensitivity C - Reactive Protein Levels for Predicting Incident Cardiovascular Events[ J]. Circulation, 2006,114:381 - 387.
7Satomi Kani, Fumiko Terasawa, Kazuyoshi Yamauchi, et al. Analysis of fibrinogen variants at 38711e shows that the side chain of 387 and the tertiary structure of the C - terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and Xllla - catalyzed - dimer formation [J]. BLOOD, 2006, 108 (6) :1887 - 1894.
8Jennifer L. Mullin, Stephen O. Brennan, Peter S. Garlly, et al. Fibrlnogen Hillsborough: a novel Gly309Asp dysfibrinogen with impaired clotting[J]. BLOOD, 2002, 99 (10) :3597 - 3601.
9Feffrey A. Kant, Susan T. Lord, Gerald R. Crabtree. Partial mRJNA sequences for human A alpha, B beta, and gamma fibrinogen chains : evolutionary and functional implications [ J ]. Proc Nail Acad Sci, 1983, 80(13) :3953 -7.
10Margaret A. Keller, Jose Martinez, Timothy C. Baradet, et al. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibfinogen hypereatabolism due to S378P mutation[J]. BLOOD, 2005, 105 (8) :3162 -3168.
